UB769
Targets5‑HT₃ receptor
IndicationsChemotherapy-induced nausea and vomiting
ClinicalCN - NDA
TherapeuticsOncology
ModalitiesSmall Molecule
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →